EU pumps EUR 2.9 million into cancer diagnostics project

The European Commission has awarded a grant of EUR 2.9 million to the COBRED project.

Funded under the Sixth Framework Programme (FP6), the COBRED project will aim to find new biomarkers for two of the most common cancers: colon cancer and breast cancer.

According to Dr Laszlo Takacs, CSO of BioSystems International, and COBRED coordinator, "This unprecedented project has the power to discover new cancer diagnostics. I am happy to see the enthusiasm of participating clinicians at the cancer centres, and of scientists at the academic and industrial laboratories."

The project will seek to develop the novel diagnostics for patient follow-up (monitoring markers) by exploiting the capacity of three state-of-the-art high-throughput technologies in an integrated systems biology approach.

After three years, COBRED hopes to deliver a set of biomarker/diagnostic candidates verified in preclinical studies, ready for large scale clinical validation and further development for commercialisation.

Furthermore, COBRED will seek to demonstrate the potential of exploring data from different high-throughput technologies and clinical profiles with advanced data mining technologies.

COBRED will also examine biomarkers for follow-up diagnostics, as novel diagnostic candidates may have the potential to aid early cancer detection via population screening. Additionally, the data gathered as part of the study may highlight poorly understood cancer mechanisms.

As breast cancer is the most common cancer in European women, and colorectal cancer is the third most common cancer type worldwide, diagnostics based on biomarkers have the potential to significantly improve current cancer disease management and diagnosis, providing higher accuracy at a lower cost.

The project consortium hopes this will lead to direct benefits for patients and society as a whole.

In addition to BioSystems International, the consortium comprises two other biotechnology firms, two large comprehensive cancer centres, three universities and a consultancy firm.

The project website will be up and running soon at the following address:
http://www.cobred.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Mayo Clinic's AI Tool Identifies 9 …

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single...

AI Detects Fatty Liver Disease with Ches…

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications...

AI Matches Doctors in Mapping Lung Tumor…

In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...